$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000163297024000057 Filed on May 14, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$499.5M	$408.6M
YoY Change	22.25%	28.11%
Cost Of Revenue	$403.6M	$370.1M
YoY Change	9.05%	28.9%
Gross Profit	$95.90M	$38.48M
YoY Change	149.2%	20.97%
Gross Profit Margin	19.2%	9.42%
Selling, General & Admin	$25.56M
YoY Change
% of Gross Profit	26.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$42.77M	$44.67M
YoY Change	-4.26%	5.58%
% of Gross Profit	44.59%	116.07%
Operating Expenses	$68.32M
YoY Change
Operating Profit	$82.18M	$66.89M
YoY Change	22.86%	-9.23%
Interest Expense	$36.44M	$39.01M
YoY Change	-6.6%	67.25%
% of Operating Profit	44.34%	58.33%
Other Income/Expense, Net	-$27.53M	-$36.30M
YoY Change	-24.17%	74.44%
Pretax Income	-$2.726M	-$27.47M
YoY Change	-90.08%	3668.45%
Income Tax	$278.0K	$143.0K
% Of Pretax Income
Net Earnings	-$3.892M	-$25.87M
YoY Change	-84.96%	775.24%
Net Earnings / Revenue	-0.78%	-6.33%
Basic Earnings Per Share	-$0.04	-$0.39
Diluted Earnings Per Share	-$0.04	-$0.39
COMMON SHARES
Basic Shares Outstanding	65.37M shares	66.03M shares
Diluted Shares Outstanding	104.3M shares	66.03M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$77.03M
YoY Change
Cash & Equivalents	$77.03M	$41.35M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$20.74M	$19.05M
Prepaid Expenses
Receivables	$215.9M
Other Receivables	$0.00
Total Short-Term Assets	$292.9M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$3.700B
YoY Change
Goodwill	$234.9M	$234.9M
YoY Change	0.0%	10.97%
Intangibles	$187.8M	$219.3M
YoY Change	-14.35%	-9.07%
Long-Term Investments	$19.41M	$15.40M
YoY Change	26.05%	-32.24%
Other Assets	$134.0M
YoY Change
Total Long-Term Assets	$4.411B
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$292.9M
Total Long-Term Assets	$4.411B
Total Assets	$4.703B	$4.748B
YoY Change	-0.93%	4.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$257.3M
YoY Change
Accrued Expenses	$219.8M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$477.1M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$2.029B
YoY Change
Other Long-Term Liabilities	$54.74M
YoY Change
Total Long-Term Liabilities	$2.084B
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$477.1M
Total Long-Term Liabilities	$2.084B
Total Liabilities	$2.561B	$3.161B
YoY Change	-18.99%	14.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.313B	-$1.181B
YoY Change	11.22%	20.41%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.961B	$1.364B
YoY Change
Total Liabilities & Shareholders Equity	$4.703B	$4.748B
YoY Change	-0.93%	4.2%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.892M	-$25.87M
YoY Change	-84.96%	775.24%
Depreciation, Depletion And Amortization	$42.77M	$44.67M
YoY Change	-4.26%	5.58%
Cash From Operating Activities	-$5.954M	$23.86M
YoY Change	-124.95%	6.72%
INVESTING ACTIVITIES
Capital Expenditures	$20.24M
YoY Change
Acquisitions	$0.00	$335.0K
YoY Change	-100.0%
Other Investing Activities	$15.02M
YoY Change
Cash From Investing Activities	-$5.223M	-$33.32M
YoY Change	-84.32%	21.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$78.00K
YoY Change		-98.11%
Debt Paid & Issued, Net	$176.1M
YoY Change
Cash From Financing Activities	$44.96M	-$14.30M
YoY Change	-414.42%	994.11%
NET CHANGE
Cash From Operating Activities	-$5.954M	$23.86M
Cash From Investing Activities	-$5.223M	-$33.32M
Cash From Financing Activities	$44.96M	-$14.30M
Net Change In Cash	$33.79M	-$23.76M
YoY Change	-242.21%	276.26%
FREE CASH FLOW
Cash From Operating Activities	-$5.954M	$23.86M
Capital Expenditures	$20.24M
Free Cash Flow	-$26.19M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2425000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1270321000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	155014000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1425335000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4577933000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	403629000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	13727000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	15195000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13053000	usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3478773000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	87984000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77026000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43445000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	47505000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	47337000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	215881000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	185379000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	187814000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180470000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	234942000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	234942000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	221575000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	227846000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	151930000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	146141000	usd
CY2024Q1	us-gaap	Assets Assets	4703430000	usd
CY2023Q4	us-gaap	Assets Assets	4577933000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	1228435000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	759308000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	1223967000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	257283000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	242905000	usd
CY2024Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	5805000	usd
CY2023Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	6095000	usd
CY2024Q1	gahr	Financing Obligations FinancingObligations	41101000	usd
CY2023Q4	gahr	Financing Obligations FinancingObligations	41756000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	219767000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	225502000	usd
CY2024Q1	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	48933000	usd
CY2023Q4	gahr	Security Deposits Prepaid Rentand Other Liabilities SecurityDepositsPrepaidRentandOtherLiabilities	76134000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	2560632000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3118755000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	11636000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	33843000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2548307000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1276222000	usd
CY2024Q1	us-gaap	Revenues Revenues	499533000	usd
CY2023Q1	us-gaap	Revenues Revenues	452226000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	370146000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11828000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2782000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	332000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42767000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44670000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	474733000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	443396000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	36438000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	39011000	usd
CY2024Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6417000	usd
CY2023Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-195000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2263000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-132000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1205000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-306000	usd
CY2024Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
CY2023Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-426000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1008000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1863000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1608000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27526000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36302000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2726000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27472000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	278000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-3004000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-27615000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	888000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1743000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3892000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25872000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104295142	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104295142	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66026173	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66026173	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-3004000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-27615000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-43000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	122000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-43000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	122000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3047000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27493000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	888000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1743000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3935000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25750000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1425335000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	772800000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	53542000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1914000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-441000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	992000	usd
CY2024Q1	gahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	15282000	usd
CY2024Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-6901000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	33076000	usd
CY2024Q1	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-2983000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2131162000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1567765000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1051000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	78000	usd
CY2023Q1	gahr	Reclassification Of Noncontrolling Interest Net ReclassificationOfNoncontrollingInterestNet	-21000	usd
CY2023Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-5043000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	16565000	usd
CY2023Q1	gahr	Net Income Lossincluding Portion Attributableto Noncontrolling Interest Excluding Preferred Stock Dividend NetIncomeLossincludingPortionAttributabletoNoncontrollingInterestExcludingPreferredStockDividend	-27247000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	122000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-21000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-368000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-3004000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-27615000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	42767000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44670000	usd
CY2024Q1	gahr	Other Amortization OtherAmortization	11799000	usd
CY2023Q1	gahr	Other Amortization OtherAmortization	20370000	usd
CY2024Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1132000	usd
CY2023Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1090000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1935000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1072000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2263000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-132000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1205000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-306000	usd
CY2024Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
CY2023Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-434000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	1063000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1280000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	6417000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Financial Instruments Used In Operating Activities IncreaseDecreaseInOtherFinancialInstrumentsUsedInOperatingActivities	-195000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	32116000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	7119000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	9736000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3489000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1866000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1790000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	8893000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	9328000	usd
CY2024Q1	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-53000	usd
CY2023Q1	gahr	Increase Decrease In Security Deposits Prepaid Rent And Other Liabilities IncreaseDecreaseInSecurityDepositsPrepaidRentAndOtherLiabilities	-5757000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5954000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23862000	usd
CY2024Q1	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	19886000	usd
CY2023Q1	gahr	Payments To Develop Real Estate Assets And Payments For Capital Expenditures PaymentsToDevelopRealEstateAssetsAndPaymentsForCapitalExpenditures	21500000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	14522000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	6901000	usd
CY2024Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	352000	usd
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	11680000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	335000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6000000	usd
CY2024Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	7753000	usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2024Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	8383000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
CY2024Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	137000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	705000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5223000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33319000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	15535000	usd
CY2023Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	7700000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	181190000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	5122000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	147600000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	113600000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	612323000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	82100000	usd
CY2024Q1	gahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	782000	usd
CY2023Q1	gahr	Payments On Financing And Other Obligations PaymentsOnFinancingAndOtherObligations	733000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5838000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1048000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	772800000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	47534000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	16596000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	26492000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	78000	usd
CY2024Q1	gahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	441000	usd
CY2023Q1	gahr	Payments To Acquire Noncontrolling Interest PaymentsToAcquireNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	991000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	4076000	usd
CY2024Q1	gahr	Repurchaseofstockwarrantsandredeemablenoncontrollinginterests Repurchaseofstockwarrantsandredeemablenoncontrollinginterests	25312000	usd
CY2023Q1	gahr	Repurchaseofstockwarrantsandredeemablenoncontrollinginterests Repurchaseofstockwarrantsandredeemablenoncontrollinginterests	15803000	usd
CY2024Q1	gahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	48000	usd
CY2023Q1	gahr	Increase Decrease In Security Deposits Financing Activities IncreaseDecreaseInSecurityDepositsFinancingActivities	-145000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44962000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14300000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	33785000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-23757000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-36000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124531000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88229000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43445000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65052000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	47337000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	46854000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90782000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111906000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77026000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41346000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	47505000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	46883000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	124531000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88229000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	35617000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	37424000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	157000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	383000	usd
CY2024Q1	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	24127000	usd
CY2023Q1	gahr	Developments And Capital Expenditures Incurred But Not Yet Paid DevelopmentsAndCapitalExpendituresIncurredButNotYetPaid	26102000	usd
CY2024Q1	gahr	Finance Leasesequipmentandautoobligationsincurred FinanceLeasesequipmentandautoobligationsincurred	353000	usd
CY2023Q1	gahr	Finance Leasesequipmentandautoobligationsincurred FinanceLeasesequipmentandautoobligationsincurred	0	usd
CY2024Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	1553000	usd
CY2023Q1	gahr	Tenant Improvement Overage TenantImprovementOverage	0	usd
CY2024Q1	gahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	91472000	usd
CY2023Q1	gahr	Noncash Or Part Noncash Acquisition Mortgage Loans Payable Acquired Net Of Loan Discount NoncashOrPartNoncashAcquisitionMortgageLoansPayableAcquiredNetOfLoanDiscount	0	usd
CY2024Q1	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	15282000	usd
CY2023Q1	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32900000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16554000	usd
CY2024Q1	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	875000	usd
CY2023Q1	gahr	Distributions Declared But Not Yet Paid To Limited Partnership Units DistributionsDeclaredButNotYetPaidToLimitedPartnershipUnits	875000	usd
CY2024Q1	gahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	294000	usd
CY2023Q1	gahr	Distributions Declared But Not Yet Paid To Restricted Stock Units DistributionsDeclaredButNotYetPaidToRestrictedStockUnits	68000	usd
CY2024Q1	gahr	Accrued Offering Costs AccruedOfferingCosts	2446000	usd
CY2023Q1	gahr	Accrued Offering Costs AccruedOfferingCosts	1255000	usd
CY2024Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	343000	usd
CY2023Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Accounts And Other Receivables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsAccountsAndOtherReceivablesAssumed	-952000	usd
CY2024Q1	gahr	Noncashor Part Noncash Acquisitionsand Disposals Increase Decreasein Other Assets NoncashorPartNoncashAcquisitionsandDisposalsIncreaseDecreaseinOtherAssets	-3749000	usd
CY2023Q1	gahr	Noncashor Part Noncash Acquisitionsand Disposals Increase Decreasein Other Assets NoncashorPartNoncashAcquisitionsandDisposalsIncreaseDecreaseinOtherAssets	162000	usd
CY2024Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	-12000	usd
CY2023Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Payables Assumed NoncashOrPartNoncashAcquisitionAndDisposalsPayablesAssumed	548000	usd
CY2024Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	0	usd
CY2023Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Financing Obligations Assumed NoncashOrPartNoncashAcquisitionAndDisposalsFinancingObligationsAssumed	12000	usd
CY2024Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	-236000	usd
CY2023Q1	gahr	Noncash Or Part Noncash Acquisition And Disposals Security Deposits Prepaid Rent And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAndDisposalsSecurityDepositsPrepaidRentAndOtherLiabilitiesAssumed	312000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. Organization and Description of Business</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview and Background</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Healthcare REIT, Inc., a Maryland corporation, is a self-managed real estate investment trust, or REIT, that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on outpatient medical buildings, senior housing, skilled nursing facilities, or SNFs, and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). Our healthcare facilities operated under a RIDEA structure include our senior housing operating properties, or SHOP, and our integrated senior health campuses. We have originated and acquired secured loans and may also originate and acquire other real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income; however, we have selectively developed, and may continue to selectively develop, healthcare real estate properties. We have elected to be taxed as a REIT for U.S. federal income tax purposes. We believe that we have been organized and operated, and we intend to continue to operate, in conformity with the requirements for qualification and taxation as a REIT under the Code. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Partnership</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct substantially all of our operations through our operating partnership, and we are the sole general partner of our operating partnership. As of March 31, 2024 and December 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we owned 97.4% and 95.0%, respectively, of the partnership units, or OP units, in our operating partnership, and the remaining 2.6% and 5.0%, respectively, limited OP units were owned by AHI Group Holdings, LLC, which is owned and controlled by Jeffrey T. Hanson, the non-executive Chairman of our board of directors, or our board, Danny Prosky, our Chief Executive Officer, President and director, and Mathieu B. Streiff, one of our directors; Platform Healthcare Investor TII, LLC; Flaherty Trust; and a wholly owned subsidiary of Griffin Capital Company, LLC, or collectively, the Limited Partners. See Note 11, Redeemable Noncontrolling Interests, and Note 12, Equity — Noncontrolling Interests in Total Equity, for a further discussion of the ownership in our operating partnership.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Offerings and Listing</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued an aggregate 65,445,557 shares of Class T common stock and Class I common stock, for a total of $2,737,716,000 in gross offering proceeds, since February 26, 2014 in our initial public offerings and our distribution reinvestment plan, or DRIP, offerings. Our initial public offerings were terminated as of April 2019.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2024, pursuant to a Registration Statement filed with the United States Securities and Exchange Commission, or SEC, on Form S-11 (File No. 333-267464), as amended, we closed our underwritten public offering, or the 2024 Offering, through which we issued 64,400,000 shares of Common Stock, for a total of $772,800,000 in gross offering proceeds. Such amounts include the exercise in full of the underwriters’ overallotment option to purchase up to an additional 8,400,000 shares of Common Stock. These shares are listed on the New York Stock Exchange, or NYSE, under the trading symbol “AHR” and began trading on February 7, 2024. </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the 2024 Offering, we are presenting Common Stock, Class T common stock and Class I common stock, or collectively, common stock, as separate classes within our condensed consolidated balance sheets and condensed consolidated statements of equity. Any references to “Common Stock” in this Quarterly Report on Form 10-Q refer to our NYSE-listed shares sold through the 2024 Offering, whereas Class T common stock and Class I common stock refer to our classes of common stock that are not NYSE-listed. This applies to all historical periods presented herein.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12, Equity — Common Stock, and Note 12, Equity — Distribution Reinvestment Plan, for a further discussion of our public offerings. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Real Estate Investments Portfolio</span></div><div style="margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate through four reportable business segments: integrated senior health campuses, outpatient medical, or OM, SHOP and triple-net leased properties. As of March 31, 2024, we owned and/or operated 318 buildings and integrated senior health campuses, representing approximately 19,451,000 square feet of gross leasable area, for an aggregate contract </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase price of $4,566,829,000. In addition, as of March 31, 2024, we also owned a real estate-related debt investment purchased for $60,429,000.</span></div>
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	gahr	Number Of Buildings And Integrated Senior Health Campuses Owned And Or Operated NumberOfBuildingsAndIntegratedSeniorHealthCampusesOwnedAndOrOperated	318	campus
CY2024Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	19451000	sqft
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price Netof Disposals AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePriceNetofDisposals	4566829000	usd
	gahr	Acquisition Aggregated Cost Of Acquired Real Estate Related Investment Purchase Price AcquisitionAggregatedCostOfAcquiredRealEstateRelatedInvestmentPurchasePrice	60429000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the initial and recurring valuation of certain assets acquired and liabilities assumed through property acquisitions including through business combinations, goodwill and its impairment, revenues and grant income, allowance for credit losses, impairment of long-lived and intangible assets and contingencies. These estimates are made and evaluated on an ongoing basis using information that is currently available, as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</span></div>
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Resident and Tenant Receivables and Allowances </span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Resident receivables, which are related to resident fees and services revenue, are carried net of an allowance for credit losses. An allowance is maintained for estimated losses resulting from the inability of residents and payors to meet the contractual obligations under their lease or service agreements. Substantially all of such allowances are recorded as direct reductions of resident fees and services revenue as contractual adjustments provided to third-party payors or implicit price concessions in our accompanying condensed consolidated statements of operations and comprehensive loss. Our determination of the adequacy of these allowances is based primarily upon evaluations of historical loss experience, the residents’ financial condition, security deposits, cash collection patterns by payor and by state, current economic conditions, future expectations in estimating credit losses and other relevant factors. Tenant receivables, which are related to real estate revenue, and unbilled deferred rent receivables are reduced for amounts where collectability is not probable, which are recognized as direct reductions of real estate revenue in our accompanying condensed consolidated statements of operations and comprehensive loss.</span></div>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17037000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14071000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	6603000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	4037000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3258000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1890000	usd
CY2024Q1	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	1856000	usd
CY2023Q1	gahr	Accounts Receivable Allowancefor Credit Loss Period Increase Decreasefrom Collectionsor Adjustments AccountsReceivableAllowanceforCreditLossPeriodIncreaseDecreasefromCollectionsorAdjustments	1827000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	18526000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14391000	usd
CY2023Q1	gahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	0	campus
CY2024Q1	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	46931000	usd
CY2023Q4	gahr	Reimbursement Of Payroll Related Costs To Managers ReimbursementOfPayrollRelatedCostsToManagers	42698000	usd
CY2024Q1	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	44691000	usd
CY2023Q4	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	44548000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	32900000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	16557000	usd
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	24374000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	23549000	usd
CY2024Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4261338000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4177595000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	782565000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	752157000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3478773000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	37135000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	35899000	usd
CY2024Q1	gahr	Capital Expenditures Incurred CapitalExpendituresIncurred	13637000	usd
CY2024Q1	gahr	Number Of Real Estate Investment To Be Disposed Of NumberOfRealEstateInvestmentToBeDisposedOf	2	usd
CY2024Q1	gahr	Contract Sale Price Of Disposition ContractSalePriceOfDisposition	11136000	usd
CY2024Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	87984000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2024Q1	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	413000	usd
CY2023Q4	gahr	Heldto Maturity Debt Securities Unamortizedclosingcosts HeldtoMaturityDebtSecuritiesUnamortizedclosingcosts	489000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1125000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1020000	usd
CY2024Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	76000	usd
CY2023Q1	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	65000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	48541000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	47540000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	187814000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	180470000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5713000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17071000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P6Y8M12D
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P7Y9M18D
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	18094000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	782000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9522000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	956000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7727000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	840000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7203000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	825000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6150000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	709000	usd
CY2024Q1	gahr	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	18913000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	1693000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	67609000	usd
CY2024Q1	gahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	5805000	usd
CY2024Q1	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	32729000	usd
CY2023Q4	gahr	Prepaid Expense Deposits Other Assets And Deferred Tax Assets PrepaidExpenseDepositsOtherAssetsAndDeferredTaxAssets	33204000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	20741000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	19472000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	19411000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	20611000	usd
CY2024Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7500000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	7231000	usd
CY2024Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17442000	usd
CY2023Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	17565000	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	5491000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	1463000	usd
CY2024Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	7117000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	8494000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5207000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3830000	usd
CY2024Q1	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2632000	usd
CY2023Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	2544000	usd
CY2024Q1	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y8M12D
CY2023	gahr	Lease Inducements Weighted Average Remaining Life LeaseInducementsWeightedAverageRemainingLife	P6Y10M24D
CY2024Q1	us-gaap	Incentive To Lessee IncentiveToLessee	2368000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	2456000	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	151930000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	146141000	usd
CY2024Q1	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	usd
CY2023Q1	gahr	Amortizationof Deferred Lease Inducements AmortizationofDeferredLeaseInducements	88000	usd
CY2024Q1	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	90	mortgageloan
CY2023Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	76	mortgageloan
CY2024Q1	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	5	mortgageloan
CY2023Q4	gahr	Number Of Variable Rate Mortgage Loans Payable NumberOfVariableRateMortgageLoansPayable	13	mortgageloan
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1255120000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1326313000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	151000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	167000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	15972000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	14371000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	1228435000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	1229847000	usd
CY2024Q1	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	15535000	usd
CY2023Q1	gahr	Proceeds From Mortgage Loans ProceedsFromMortgageLoans	7700000	usd
CY2024Q1	gahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	91472000	usd
CY2023Q1	gahr	Assumption Of Debt In Business Combination AssumptionOfDebtInBusinessCombination	0	usd
CY2024Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	780000	usd
CY2023Q1	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	577000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1374000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	885000	usd
CY2024Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	5045000	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	5122000	usd
CY2024Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	176145000	usd
CY2023Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	0	usd
CY2024Q1	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	1932000	usd
CY2023Q1	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	142000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	1228435000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	1233745000	usd
CY2024Q1	gahr	Early Payoff Of Mortgage Payable EarlyPayoffOfMortgagePayable	176145000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	177717000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	168275000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	158331000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	55125000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	105126000	usd
CY2024Q1	gahr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	590546000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1255120000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6417000	usd
CY2023Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-195000	usd
CY2023Q4	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2024Q1	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	33843000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	81598000	usd
CY2024Q1	gahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-21000	usd
CY2023Q1	gahr	Noncontrolling Interest Reclassification From Equity NoncontrollingInterestReclassificationFromEquity	-21000	usd
CY2024Q1	gahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	15303000	usd
CY2023Q1	gahr	Noncontrolling Interest Reclassification To Equity NoncontrollingInterestReclassificationToEquity	0	usd
CY2024Q1	gahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	3000	usd
CY2023Q1	gahr	Redeemable Noncontrolling Interest Distributions RedeemableNoncontrollingInterestDistributions	454000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	15870000	usd
CY2024Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-6901000	usd
CY2023Q1	gahr	Adjustments To Additional Paid In Capital Adjustment To Redeemable Noncontrolling Interests AdjustmentsToAdditionalPaidInCapitalAdjustmentToRedeemableNoncontrollingInterests	-5043000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-21000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-368000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	11636000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	59884000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	724625000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	176145000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	545010000	usd
CY2023Q1	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	37.16
CY2023Q4	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2024Q1	gahr	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest With Redemption Features Outstanding LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterestWithRedemptionFeaturesOutstanding	0.010
CY2024Q1	gahr	Operating Partnership Units Outstanding Presented In Total Equity Percent OperatingPartnershipUnitsOutstandingPresentedInTotalEquityPercent	0.026
CY2024Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	87984000	usd
CY2024Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93323000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	86935000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	93304000	usd
CY2024Q1	us-gaap	Secured Debt SecuredDebt	1228435000	usd
CY2024Q1	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1090173000	usd
CY2023Q4	us-gaap	Secured Debt SecuredDebt	1302396000	usd
CY2023Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	1185260000	usd
CY2024Q1	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	754101000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	759966000	usd
CY2023Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	1220137000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	1225890000	usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	91000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	11000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1155000	usd
CY2024Q1	gahr	Operating Lease Revenue OperatingLeaseRevenue	46008000	usd
CY2023Q1	gahr	Operating Lease Revenue OperatingLeaseRevenue	42303000	usd
CY2024Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	9659000	usd
CY2023Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	10040000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	101827000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	127211000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	117487000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	111745000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	100456000	usd
CY2024Q1	gahr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	486642000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1045368000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	10776000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	11923000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	561000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	303000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	157000	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	91000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	144000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	156000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	11350000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	12161000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y2M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0577
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0576
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0779
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0778
CY2024Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	157000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	26936000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	35153000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	35074000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	35617000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	35707000	usd
CY2024Q1	gahr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	166314000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	334801000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	115034000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	219767000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	63000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	31000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q1	gahr	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	94000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	5000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	89000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	6	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	452118000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	47415000	usd
CY2024Q1	us-gaap	Revenues Revenues	499533000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	403629000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	13727000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	82177000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11828000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2782000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	42767000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	36438000	usd
CY2024Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	6417000	usd
CY2024Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	2263000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1205000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-426000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1863000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27526000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2726000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	278000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-3004000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	408630000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	43596000	usd
CY2023Q1	us-gaap	Revenues Revenues	452226000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	370146000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	15195000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	66885000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13053000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	332000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44670000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	39011000	usd
CY2023Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-195000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-132000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-306000	usd
CY2023Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	726000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1008000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1608000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-36302000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27472000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	143000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-27615000	usd
CY2024Q1	us-gaap	Assets Assets	4703430000	usd
CY2023Q4	us-gaap	Assets Assets	4577933000	usd
CY2024Q1	us-gaap	Revenues Revenues	499533000	usd
CY2023Q1	us-gaap	Revenues Revenues	452226000	usd
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3478773000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3425438000	usd
CY2024Q1	gahr	Concentration Risk Number Of States That Generated At Least Ten Percent Of Annualized Base Rent ConcentrationRiskNumberOfStatesThatGeneratedAtLeastTenPercentOfAnnualizedBaseRent	2	state
CY2024Q1	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.100
CY2024Q1	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	0	tenant
CY2024Q1	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	1095000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	926000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001632970-24-000057-index-headers.html	Edgar Link	pending
0001632970-24-000057-index.html	Edgar Link	pending
0001632970-24-000057.txt	Edgar Link	pending
0001632970-24-000057-xbrl.zip	Edgar Link	pending
ex105-2024xq110xqahr.htm	Edgar Link	pending
ex311-2024xq110xqahr.htm	Edgar Link	pending
ex312-2024xq110xqahr.htm	Edgar Link	pending
ex321-2024xq110xqahr.htm	Edgar Link	pending
ex322-2024xq110xqahr.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gahr-20240331.htm	Edgar Link	pending
gahr-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
gahr-20240331_def.xml	Edgar Link	unprocessable
gahr-20240331_lab.xml	Edgar Link	unprocessable
gahr-20240331_pre.xml	Edgar Link	unprocessable
gahr-20240331_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gahr-20240331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2024 Q1 Form 10-Q Financial Statement

#000163297024000057 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2024 Q1 Form 10-Q Financial Statement

#000163297024000057 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr